Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection

scientific article published on 14 June 2016

Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/V8060167
P932PMC publication ID4926187
P698PubMed publication ID27314377

P50authorKelly M. McMastersQ55615790
Pei-Hsin ChengQ87689932
P2093author name stringH Sam Zhou
Jorge G Gomez-Gutierrez
Xiao-Mei Rao
Stephen L Wechman
P2860cites workFunctions of the adenovirus E1B tumour antigens.Q53540498
[Phase II clinical study of intratumoral H101, an E1B deleted adenovirus, in combination with chemotherapy in patients with cancer]Q64377248
Gene expression profiles of normal human lung cells affected by adenoviral E1BQ64377980
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studiesQ64378032
E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cellsQ64379383
A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violetQ71850183
Reduced expression of microtubule-associated protein 1 light chain 3 in hypertrophic scarsQ83214323
Oncolytic virotherapyQ38025263
Too much or not enough of a good thing--The Janus faces of autophagy in cardiac fuel and protein homeostasisQ38377805
Isolation of more potent oncolytic paramyxovirus by bioselectionQ39392034
Verapamil enhances the antitumoral efficacy of oncolytic adenovirusesQ39735941
Bak and Bax function to limit adenovirus replication through apoptosis inductionQ39752946
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency.Q39923110
Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.Q40018751
Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell deathQ40277603
Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.Q40341364
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.Q41563742
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosisQ41563751
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cellsQ41975913
Advantages and disadvantages of multiple different methods of adenoviral vector constructionQ44267578
A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer modelsQ44984285
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapyQ45247385
Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo.Q45862986
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trialQ45876506
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomasQ45880512
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingQ24597817
Oncolytic Replication of E1b-Deleted AdenovirusesQ26777406
Molecular dissection of autophagy: two ubiquitin-like systemsQ28206420
Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin EQ28486255
Development by self-digestion: molecular mechanisms and biological functions of autophagyQ29547880
Current issues and future directions of oncolytic adenovirusesQ33730705
A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumorsQ33730735
To cycle or not to cycle: a critical decision in cancer.Q33957955
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?Q34225918
Autophagy: assays and artifactsQ34341096
An adenovirus mutant that replicates selectively in p53-deficient human tumor cellsQ34399844
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trialsQ34452020
Developing novel oncolytic adenoviruses through bioselectionQ34471952
Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfectionQ34562704
Adenovirus and cell cycle controlQ34625673
Adenoviruses induce autophagy to promote virus replication and oncolysis.Q35040642
Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoterQ35058583
Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomasQ35234338
Cancer-specific viruses and the development of ONYX-015Q35542812
Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent miceQ35811062
Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trialQ36180392
Recent progress in the battle between oncolytic viruses and tumoursQ36315580
Clinical trials with oncolytic adenovirus in ChinaQ36754441
Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancerQ36803773
The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor αQ36816831
Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancerQ37063332
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteinsQ37162513
Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cellsQ37362758
Oncolytic viral therapy of malignant gliomaQ37533665
Strategies to enhance viral penetration of solid tumorsQ37858538
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectAdenoviridaeQ193447
oncolytic virusQ1560099
P577publication date2016-06-14
P1433published inVirusesQ7935305
P1476titleDevelopment of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection
P478volume8

Reverse relations

cites work (P2860)
Q37539305Adenovirus with DNA Packaging Gene Mutations Increased Virus Release
Q64374652Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy
Q54207869Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.
Q47564266Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis
Q57171688The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy

Search more.